1
|
Li D, Wu LJ, Tashiro SI, Onodera S and
Ikejima T: Oridonin-induced A431 cell apoptosis partially through
blockage of the Ras/Raf/ERK signal pathway. J Pharmacol Sci.
103:56–66. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Huang J, Wu L, Tashiro S, Onodera S and
Ikejima T: A comparison of the signal pathways between the TNF
alpha- and oridonin-induced murine L929 fibrosarcoma cell death.
Acta Med Okayama. 59:261–270. 2005.
|
3
|
Bai NS, He K, Zhou Z, et al: Flavonoids
from Rabdosia rubescens exert anti-inflammatory and growth
inhibitory effect against human leukemia HL-60 cells. Food Chem.
122:831–835. 2010. View Article : Google Scholar
|
4
|
Gui MY, Aoyagi Y, Jin YR, Li XW, Hasuda T
and Takeya K: Excisanin H, a novel cytotoxic
14,20-epoxy-ent-kaurene diterpenoid and three new ent-kaurene
diterpenoids from Rabdosia excisa. J Nat Prod. 67:373–376. 2004.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Huang ZY, Huang B, Xiao CJ, Dong X and
Jiang B: Two new labdane diterpenoids from the rhizomes of Isodon
yuennanensis. Nat Prod Res. 29:628–632. 2015. View Article : Google Scholar
|
6
|
Wu HY, Wang WG, Jiang HY, Du X, Li XN, Pu
JX and Sun HD: Cytotoxic and anti-inflammatory ent-kaurane
diterpenoids from Isodon wikstroemioides. Fitoterapia. 98:192–198.
2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. Ca-Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Dores GM, Huycke MM and Devesa SS:
Melanoma of the skin and laterality. J Am Acad Dermatol.
64:193–195. 2011. View Article : Google Scholar
|
9
|
Ahmed I: Malignant melanoma: Prognostic
indicators. Mayo Clin Proc. 72:356–361. 1997. View Article : Google Scholar : PubMed/NCBI
|
10
|
Minhajat R, Mori D, Yamasaki F, Sugita Y,
Satoh T and Tokunaga O: Endoglin (CD105) expression in angiogenesis
of colon cancer: Analysis using tissue microarrays and comparison
with other endothelial markers. Virchows Arch. 448:127–134. 2006.
View Article : Google Scholar
|
11
|
Uneda S, Toi H, Tsujie T, Tsujie M, Harada
N, Tsai H and Seon BK: Anti-endoglin monoclonal antibodies are
effective for suppressing metastasis and the primary tumors by
targeting tumor vasculature. Int J Cancer. 125:1446–1453. 2009.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Lee SY, Hong YD, Felipe PM, Pyun MS and
Choi SJ: Radiolabeling of monoclonal anti-CD105 with (177) Lu for
potential use in radioimmunotherapy. Appl Radiat Isot.
67:1366–1369. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ozaki T and Nakagawara A: Role of p53 in
cell death and human cancers. Cancers (Basel). 3:994–1013. 2011.
View Article : Google Scholar
|
14
|
Bartek J and Lukas J: Chk1 and Chk2
kinases in checkpoint control and cancer. Cancer cell. 3:421–429.
2003. View Article : Google Scholar : PubMed/NCBI
|
15
|
Senderowicz AM: Novel direct and indirect
cyclin-dependent kinase modulators for the prevention and treatment
of human neoplasms. Cancer Chemother Pharmacol. 52:S61–S73. 2003.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen Y and Sanchez Y: Chk1 in the DNA
damage response: conserved roles from yeasts to mammals. DNA
Repair. 3:1025–1032. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Carpi S, Fogli S, Romanini A, Pellegrino
M, Adinolfi B, Podestà A, Costa B, Da Pozzo E, Martini C, Breschi
MC and Nieri P: AM251 induces apoptosis and G2/M cell cycle arrest
in A375 human melanoma cells. Anticancer Drugs. May 12–2015.Epub
ahead of print. View Article : Google Scholar : PubMed/NCBI
|
19
|
Peng ZG, Yao YB, Yang J, Tang YL and Huang
X: Mangiferin induces cell cycle arrest at G2/M phase through
ATR-Chk1 pathway in HL-60 leukemia cells. Genet Mol Res.
14:4989–5002. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Qi W, Xie C, Li C, Caldwell JT, Edwards H,
Taub JW, Wang Y, Lin H and Ge Y: CHK1 plays a critical role in the
anti-leukemic activity of the wee1 inhibitor MK-1775 in acute
myeloid leukemia cells. J Hematol Oncol. 7:532014. View Article : Google Scholar : PubMed/NCBI
|